Yannes v. SCWorx Corp. et al
Case Number:
1:20-cv-03349
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
February 14, 2022
Contractor, Investors Reach $3.3M Deal In COVID Tests Suit
Investors in SCWorx Corp. have reached a $3.3 million settlement with the health care logistics company to resolve claims that it misled investors when it announced a major COVID-19 test kit contract in the early days of the pandemic.
-
November 19, 2020
Contractor Fights Investors' Claims Over COVID Test Kit Deal
Hospital contractor SCWorx and its chief executive told a Manhattan federal judge on Wednesday that a proposed class of investors failed to show that the company had lied in connection with a COVID-19 test supply deal that purportedly fell apart in the spring.
-
September 18, 2020
Kaplan Fox Nabs Lead In Investors' Rapid Virus Tests Suit
Kaplan Fox & Kilsheimer LLP will represent a proposed class of investors in a suit alleging hospital contractor SCWorx "overstated or entirely fabricated" its announcement in April that it would soon earn millions weekly by supplying COVID-19 rapid testing kits.
-
June 30, 2020
Legal Teams Vie To Lead COVID Test Supply Stock Drop Suit
Four legal teams are competing to represent a proposed class of investors in Manhattan federal court suit accusing health care analytics company SCWorx Corp. of securities fraud after the firm landed on a list of public companies subject to U.S. Securities and Exchange Commission trading suspensions linked to claims about combating coronavirus.
-
May 29, 2020
COVID-19 Securities Catch-Up: The 8 Biggest Investor Actions
At least 50 federal securities cases with references to COVID-19 have been filed in the past three months, including merger challenges, regulatory enforcement actions and sprawling investor suits, according to a Law360 review of filings. As the pandemic pushes into the summer, Law360 is taking a look at eight major investor actions that were brought in connection with the novel coronavirus since March.
-
April 30, 2020
'Bogus' COVID-19 Test-Kit Deal Draws Investor Fraud Lawsuit
Investors slapped a health care supplier with a proposed securities fraud class action on Wednesday, claiming it misled them by boasting it was poised to sell millions of COVID-19 rapid testing kits in a deal that turned out to be backed by alleged fraudsters and convicted felons.